Home Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management
Article
Licensed
Unlicensed Requires Authentication

Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management

  • Luca Giovanella
Published/Copyright: June 20, 2008

Abstract

Differentiated thyroid cancer is an infrequent disease with a generally good prognosis. The initial treatment is total thyroidectomy coupled with ablation of thyroid remnants by iodine-131. Because thyroid cells are the only source of thyroglobulin in the human body, the circulating thyroglobulin measurement is the basis of differentiated thyroid cancer follow-up. Due to suboptimal sensitivity in older assays, the thyroglobulin measurements after stimulation by endogenous or exogenous thyrotropin are still recommended for unmasking occult disease. However, the development of thyroglobulin assays with improved functional sensitivity allows us to detect small amounts of thyroid tissue even when thyrotropin is suppressed. As a consequence, undetectable thyroglobulin during thyroxine treatment is sufficient evidence to forgo thyrotropin stimulation in many cases, if a highly sensitive assay is employed. On the other hand, increasing concentrations in highly sensitive assays are an early and reliable indicator of recurrent disease. This will result in a limited follow-up protocol, warranting the detection of recurrences of differentiated thyroid cancer and reducing patient burden and medical costs.

Clin Chem Lab Med 2008;46:1067–73.


Corresponding author: Dr. med. Luca Giovanella, Department of Nuclear Medicine, PET Center and Thyroid Unit, Oncology Institute of Southern Switzerland, Via Ospedale 12, 6500 Bellinzona, Switzerland Phone: +41-91-811-8672, Fax: +41-91-811-8250,

Received: 2007-12-20
Accepted: 2008-4-1
Published Online: 2008-06-20
Published in Print: 2008-08-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Review
  2. Insulin-like growth factor-I and complications of prematurity: a focus on bronchopulmonary dysplasia
  3. Minireview
  4. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management
  5. Genetics and Molecular Diagnostics
  6. Proteomic pattern of plasma in off-pump coronary artery bypass surgery
  7. Association of CHRNA2 polymorphisms with overweight/obesity and clinical characteristics in a Korean population
  8. Relevance of glutathione S-transferase M1 and cytochrome P450 1A1 genetic polymorphisms to the development of head and neck cancers
  9. Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction in Tunisian patients
  10. The influence of smoking and homocysteine on subclinical atherosclerosis is modified by the connexin37 C1019T polymorphism – The Cardiovascular Risk in Young Finns Study
  11. Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP
  12. An improved quality control for bisulfite-PCR-based DNA methylation analysis: cycle threshold value
  13. General Clinical Chemistry and Laboratory Medicine
  14. Can E-cadherin and CD34 be used as indicators of prognosis for hepatocellular carcinoma patients?
  15. Determination of serum creatinine by Jaffe method and how to calibrate to eliminate matrix interference problems
  16. Calcium oxalate stone formation risk – a case of disturbed relative concentrations of urinary components
  17. Half-lives of albumin and cholinesterase in critically ill patients
  18. Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood
  19. Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-α levels in patients with ischemic heart disease
  20. Estimation of serum M-protein concentration from polyclonal immunoglobulins: an alternative to serum protein electrophoresis and standard immunochemical procedures
  21. Are serum lipids measured on stroke admission prognostic?
  22. Reference Values and Biological Variations
  23. Pre-analytical variation of some haematological quantities
  24. Long-term stability of endogenous B-type natriuretic peptide after storage at –20°C or –80°C
  25. Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations?
  26. Non-homogeneous separation of triglycerides, γ-glutamyltransferase, C-reactive protein and lactate dehydrogenase after centrifugation of lithium-heparin tubes
  27. Validation and Outcome Studies
  28. Computer-assisted detection of monoclonal components: results from the multicenter study for the evaluation of CASPER (Computer Assisted Serum Protein Electrophoresis Recognizer) algorithm
  29. Quality indicators and specifications for strategic and support processes in laboratory medicine
  30. Evaluation of the DCA Vantage analyzer for HbA1c assay
  31. Letters to the Editor
  32. Optimization of imprecision and cost saving on hemoglobin A1c controls through aliquot freezing
  33. Estimation of glomerular filtration rate by the modification of diet in renal disease (MDRD) equation in patients with sickle cell disease
  34. Abstracts
  35. Swiss MedLab 2008: International Congress, September 16–19, 2008, Montreux, Switzerland
  36. 4th Biologie Prospective Santorini Conference, September 21–23, 2008, Santorini, Greece
Downloaded on 13.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.212/html
Scroll to top button